Three-year outcomes following sirolimus-versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry)

American Journal of Cardiology

Volumn 106, Issue 4, 2010, Pages 504-510

  Hanna, Nicholas N ^a   Gaglia Jr , Michael A ^a   Torguson, Rebecca ^a   Ben Dor, Itsik ^a   Gonzalez, Manuel A ^a   Collins, Sara D ^a   Syed, Asmir I ^a   Maluenda, Gabriel ^a   Kaneshige, Kimberly ^a   Xue, Zhenyi ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Suddath, William O ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HIRULOG; PACLITAXEL; RAPAMYCIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DISEASE REGISTRY; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; IMPLANTATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; Q WAVE; REVASCULARIZATION; SAFETY; STENT THROMBOSIS; COMPARATIVE STUDY; CORONARY THROMBOSIS; DIABETES MELLITUS; FOLLOW UP; MIDDLE AGED; REGISTER; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; REGISTRIES; SIROLIMUS; TREATMENT OUTCOME; ANGIOPLASTY, BALLOON, CORONARY;

EID: 77955452438     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.04.001     Document Type: Article

References (33)

1. G.W. Stone, J.W. Moses, S.G. Ellis, J. Schofer, K.D. Dawkins, M.C. Morice, A. Colombo, E. Schampaert, E. Grube, A.J. Kirtane, D.E. Cutlip, M. Fahy, S.J. Pocock, R. Mehran, and M.B. Leon Safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
2. J. Cosgrave, G. Melzi, S. Corbett, G.G. Biondi-Zoccai, P. Agostoni, R. Babic, F. Airoldi, A. Chieffo, G.M. Sangiorgi, M. Montorfano, I. Michev, M. Carlino, and A. Colombo Comparable clinical outcomes with paclitaxel-and sirolimus-eluting stents in unrestricted contemporary practice J Am Coll Cardiol 49 2007 2320 2328
3. C.A. Simonton, B. Brodie, B. Cheek, F. Krainin, C. Metzger, J. Hermiller, S. Juk, P. Duffy, A. Humphrey, M. Nussbaum, and S. Laurent Comparative clinical outcomes of paclitaxel-and sirolimus-eluting stents: results from a large prospective multicenter registrySTENT Group J Am Coll Cardiol 50 2007 1214 1222
4. M. Mayor, A.Z. Malik, R.J. Minor Jr, M.C. Deshpande, W.E. Strauss, T.H. Maloney, D.S. Baim, W. O'Neill, and D.E. Kandzari One-year outcomes from the TAXUS express stent versus cypher stent Am J Cardiol 103 2009 930 936
5. A.M. Galloe, L. Thuesen, H. Kelbaek, P. Thayssen, K. Rasmussen, P.R. Hansen, N. Bligaard, K. Saunamaki, A. Junker, J. Aaroe, U. Abildgaard, J. Ravkilde, T. Engstrom, J.S. Jensen, H.R. Andersen, H.E. Botker, S. Galatius, S.D. Kristensen, J.K. Madsen, L.R. Krusell, S.Z. Abildstrom, G.B. Stephansen, and J.F. Lassen Comparison of paclitaxel-and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial JAMA 299 2008 409 416
6. A. Schomig, A. Dibra, S. Windecker, J. Mehilli, J. Suarez de Lezo, C. Kaiser, S.J. Park, J.J. Goy, J.H. Lee, E. Di Lorenzo, J. Wu, P. Juni, M.E. Pfisterer, B. Meier, and A. Kastrati A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease J Am Coll Cardiol 50 2007 1373 1380
7. M. Joner, A.V. Finn, A. Farb, E.K. Mont, F.D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H.K. Gold, and R. Virmani Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
8. H.S. Gurm, T. Boyden, and K.B. Welch Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis Am Heart J 155 2008 630 639
9. P. Wenaweser, J. Daemen, M. Zwahlen, R. van Domburg, P. Juni, S. Vaina, G. Hellige, K. Tsuchida, C. Morger, E. Boersma, N. Kukreja, B. Meier, P.W. Serruys, and S. Windecker Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice 4-Year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
10. A.A. Bavry, D.J. Kumbhani, T.J. Helton, P.P. Borek, G.R. Mood, and D.L. Bhatt Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials Am J Med 119 2006 1056 1061
11. N.E. West, P.N. Ruygrok, C.M. Disco, M.W. Webster, W.K. Lindeboom, W.W. O'Neill, N.F. Mercado, and P.W. Serruys Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients Circulation 109 2004 867 873
12. N.W. Niles, P.D. McGrath, D. Malenka, H. Quinton, D. Wennberg, S.J. Shubrooks, J.F. Tryzelaar, R. Clough, M.J. Hearne, F. Hernandez Jr, M.W. Watkins, and G.T. O'Connor Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study Northern New England Cardiovascular Disease Study Group J Am Coll Cardiol 37 2001 1008 1015
13. K.D. Dawkins, G.W. Stone, A. Colombo, E. Grube, S.G. Ellis, J.J. Popma, P.W. Serruys, P. Lam, J. Koglin, and M.E. Russell Integrated analysis of medically treated diabetic patients in the TAXUS(R) program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatments Eurointervention 2 2006 61 68
14. S.W. Lee, S.W. Park, Y.H. Kim, S.C. Yun, D.W. Park, C.W. Lee, M.K. Hong, K.S. Rhee, J.K. Chae, J.K. Ko, J.H. Park, J.H. Lee, S.W. Choi, J.O. Jeong, I.W. Seong, Y.H. Cho, N.H. Lee, J.H. Kim, K.J. Chun, H.S. Kim, and S.J. Park A randomized comparison of sirolimus-versus paclitaxel-eluting stent implantation in patients with diabetes mellitus J Am Coll Cardiol 52 2008 727 733
15. S.W. Lee, S.W. Park, Y.H. Kim, S.C. Yun, D.W. Park, C.W. Lee, M.K. Hong, K.S. Rhee, J.K. Chae, J.K. Ko, J.H. Park, J.H. Lee, S.W. Choi, J.O. Jeong, I.W. Seong, Y.H. Cho, N.H. Lee, J.H. Kim, K.J. Chun, H.S. Kim, and S.J. Park A randomized comparison of sirolimus-versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial J Am Coll Cardiol 53 2009 812 813
16. M. Maeng, L.O. Jensen, A.M. Galloe, P. Thayssen, E.H. Christiansen, K.N. Hansen, S. Helqvist, H.E. Botker, J.F. Lassen, and L. Thuesen Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial Am J Cardiol 103 2009 345 349
17. F. Zhang, L. Dong, and J. Ge Meta-analysis of five randomized clinical trials comparing sirolimus-versus paclitaxel-eluting stents in patients with diabetes mellitus Am J Cardiol 105 2010 64 68
18. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, and P.W. Serruys Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
19. J. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
20. R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
21. H. Putter, M. Fiocco, and R.B. Geskus Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 2007 2389 2430
22. E. Bodnar, S. Haberman, and W.H. Wain Comparative method for actuarial analysis of cardiac valve replacements Br Heart J 42 1979 541 552
23. E.H. Blackstone, and J.W. Kirklin Death and other time-related events after valve replacement Circulation 72 1985 753 767
24. J. Daemen, K. Tsuchida, G.G. Stefanini, S. Vaina, N. Kukreja, P.P. de Jaegere, A.T. Ong, R.T. van Domburg, and P.W. Serruys Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry Eurointervention 2 2006 330 337
25. A. Kaltoft, L.O. Jensen, M. Maeng, H.H. Tilsted, P. Thayssen, M. Bottcher, J.F. Lassen, L.R. Krusell, K. Rasmussen, K.N. Hansen, L. Pedersen, S.P. Johnsen, H.T. Sorensen, and L. Thuesen 2-Year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry) J Am Coll Cardiol 53 2009 658 664
26. M.C. Morice, A. Colombo, B. Meier, P. Serruys, C. Tamburino, G. Guagliumi, E. Sousa, and H.P. Stoll Sirolimus-vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial JAMA 295 2006 895 904
27. C. Stettler, S. Wandel, S. Allemann, A. Kastrati, M.C. Morice, A. Schomig, M.E. Pfisterer, G.W. Stone, M.B. Leon, J.S. de Lezo, J.J. Goy, S.J. Park, M. Sabate, M.J. Suttorp, H. Kelbaek, C. Spaulding, M. Menichelli, P. Vermeersch, M.T. Dirksen, P. Cervinka, A.S. Petronio, A.J. Nordmann, P. Diem, B. Meier, M. Zwahlen, S. Reichenbach, S. Trelle, S. Windecker, and P. Juni Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948 (Pubitemid 47393576)
28. C. Stettler, S. Allemann, S. Wandel, A. Kastrati, M.C. Morice, A. Schomig, M.E. Pfisterer, G.W. Stone, M.B. Leon, J.S. de Lezo, J.J. Goy, S.J. Park, M. Sabate, M.J. Suttorp, H. Kelbaek, C. Spaulding, M. Menichelli, P. Vermeersch, M.T. Dirksen, P. Cervinka, M. De Carlo, A. Erglis, T. Chechi, P. Ortolani, M.J. Schalij, P. Diem, B. Meier, S. Windecker, and P. Juni Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis BMJ 337 2008 a1331
29. P.K. Kuchulakanti, W.W. Chu, R. Torguson, L. Clavijo, R. Wolfram, S. Mishra, Z. Xue, N. Gevorkian, W.O. Suddath, L.F. Satler, K.M. Kent, A.D. Pichard, and R. Waksman Sirolimus-eluting stents versus paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus Am J Cardiol 98 2006 187 192 (Pubitemid 43975495)
30. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
31. G. Sandhu, B. Doyle, R. Singh, M. Bell, J. Bresnahan, V. Mathew, D. Holmes, A. Lerman, and C. Rihal Frequency, etiology, treatment, and outcomes of drug-eluting stent thrombosis during one year of follow-up Am J Cardiol 99 2007 465 469
32. D.O. Williams, J.D. Abbott, and K.E. Kip Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry Circulation 114 2006 2154 2162
33. J. Daemen, P. Wenaweser, K. Tsuchida, L. Abrecht, S. Vaina, C. Morger, N. Kukreja, P. Juni, G. Sianos, G. Hellige, R.T. van Domburg, O.M. Hess, E. Boersma, B. Meier, S. Windecker, and P.W. Serruys Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678